BusinessCann
BusinessCann · page 17
- News
Helping Create ‘A Loud, Proud, Clean, Transparent, Open, Thoughtful, And Considerate Cannabis Industry’
Writing for BusinessCann Toby Shillito, Chair of the Cannabis Industry Council’s Environmental & Social Responsibility Subgroup, elaborates on the importance of corporate responsibility in an industry ‘born with reputational issues’.
- Press releases
Cellular Goods Announces Launch of Inaugural Product Range and Ecommerce Platform
Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the launch today of its inaugural product ranges and ecommerce platform, found at cellulargoods.co.
- Pharmaceutical
Óskare Capital Announces Launch of First Medical Cannabis SEIS & EIS Fund
Óskare Capital is proud to announce the launch of the first ever SEIS and EIS fundtargeting the Medical and Pharmaceutical Cannabis sector. Óskare Capital UK will advisethe Fund which is managed by Sapphire Capital Partners LLP.
- Hemp Industry
SynBiotic SE Buys Hemp Pioneer’s Group Of Companies For €11.2m
It is the most significant merger in the European cannabis sector.
- Press releases
STENOCARE Comments On The Business Perspective Of Its Danish Indoor Cultivation Facility
Following the completion of the Danish facility upgrade, STENOCARE has shared three video tours from inside the facility.
- CBD Market
Transatlantic Knowledge Transfer: What Europe Can Learn From New York’s Cannabis Legalisation Initiatives
By Adrian Clarke, Chief Commercial Officer at Tenacious Labs 2021 is proving to be been a momentous one for the cannabis industry.
- Pharmaceutical
Oxford Cannabinoid Technologies Holdings Signs New Agreement With Dalriada Drug Discovery
Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”, together, the “Group”), a company developing licensed prescription cannabinoid medicines for approval by regulatory agencies worldwide and targeting the U$ multi-billion pain market, is pleased to announce that OCT has signed an important new drug development agreement with Dalriada.
- Companies
From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US.
- Press releases
Akanda Corp Closes $5m Private Placement
Akanda Corp has announced that it has closed a private placement for aggregate gross proceeds of $5,316,000.
- Pharmaceutical
Oxford Cannabinoid Technologies Signs New Agreement With Stemtech
OCT believes Stemtech’s technology provides an in vitro translational model that will better predict results in humans.
- Press releases
Akanda’s CanMart Subsidiary To Distribute Award-Winning Cannim Cannabis Products To UK Patients
Akanda Corp has announced that its wholly-owned subsidiary, CanMart has entered into a distribution agreement with Australia-based Cannim to bring the award-winning Lumir range of medical cannabis products to UK patients.
